Last reviewed · How we verify
GBS trivalent vaccine
Stimulates the immune system to produce antibodies against the influenza virus, RSV, and Hib.
Stimulates the immune system to produce antibodies against the influenza virus, RSV, and Hib. Used for Influenza, RSV infection, Hib infection.
At a glance
| Generic name | GBS trivalent vaccine |
|---|---|
| Sponsor | GlaxoSmithKline |
| Drug class | Influenza vaccine, RSV vaccine, Hib vaccine |
| Modality | Biologic |
| Therapeutic area | Vaccines |
| Phase | Phase 2 |
Mechanism of action
The GBS trivalent vaccine works by introducing inactivated influenza virus, RSV, and Hib antigens to the body, which triggers an immune response and the production of antibodies to fight these pathogens.
Approved indications
- Influenza
- RSV infection
- Hib infection
Common side effects
- Pain, redness, or swelling at the injection site
- Fever
- Fatigue
Key clinical trials
- Extension Study to Evaluate the Immunogenicity and Safety of the Second Dose of GBS Trivalent Vaccine in Healthy Non-Pregnant Subjects. (PHASE2)
- Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women (PHASE2)
- Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine (PHASE2)
- Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings (PHASE2)
- Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings (PHASE2)
- Safety and Immunogenicity of a Group B Streptococcus Vaccine in Non Pregnant and Pregnant Women 18-40 Years of Age (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GBS trivalent vaccine CI brief — competitive landscape report
- GBS trivalent vaccine updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI